BMSSC
ONC

B. Metzler seel. Sohn & Co’s BeOne Medicines Ltd ONC Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
6,706
+2,840
+73% +$837K 0.02% 427
2026
Q1 		$1.15M Buy
3,866
+1,297
+50% +$420K 0.01% 512
2025
Q4 		$780K Hold
2,569
– – 0.01% 579
2025
Q3 		$875K Buy
2,569
+1,021
+66% +$310K 0.01% 567
2025
Q2 		$375K Buy
1,548
+807
+109% +$198K ﹤0.01% 673
2025
Q1 		$202K Buy
+741
New +$173K ﹤0.01% 734

Other funds holding ONC

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

B. Metzler seel. Sohn & Co's ONC Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its BeOne Medicines Ltd (ONC) stake by 73% in Q2 2026, buying an estimated $837K and bringing the position to 6,706 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #427.

B. Metzler seel. Sohn & Co first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 6,706 shares of BeOne Medicines Ltd worth $1.91M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 2,840 BeOne Medicines Ltd shares in Q2 2026, an estimated $837K.
  • BeOne Medicines Ltd made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #427 holding.
  • B. Metzler seel. Sohn & Co first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • 147 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.